Al Hammadi Holding reported a net profit of SAR 64 million for Q1 2023, a decline of 21% from SAR 81 million a year earlier.
Item | Q1 2023 | Q1 2024 | Change |
---|---|---|---|
Revenues | 298.60 | 277.04 | (7.2 %) |
Gross Income | 120.20 | 91.06 | (24.2 %) |
Operating Income | 87.24 | 68.17 | (21.9 %) |
Net Income | 81.42 | 64.04 | (21.3 %) |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.51 | 0.40 | (21.3 %) |
Item | Q4 2023 | Q1 2024 | Change |
---|---|---|---|
Revenues | 303.68 | 277.04 | (8.8 %) |
Gross Income | 106.45 | 91.06 | (14.5 %) |
Operating Income | 59.10 | 68.17 | 15.3 % |
Net Income | 65.19 | 64.04 | (1.8 %) |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.41 | 0.40 | (1.8 %) |
The annual profit decline was attributed to a 7.2% revenue drop and higher costs due to increase in medical staff costs owing to yearly raises and new hires to staff Al Hammadi’s capacity expansions and new service offerings.
The healthcare services provider’s Q1 2024 net profit fell 1.8% from SAR 65.19 million in the previous quarter.
Shareholders’ equity, no minority interest, increased to SAR 1.85 billion by the end of Q1 2024, from SAR 1.73 billion a year earlier.
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
Q1 2015 | 129.48 | 6.1 % | 50.64 | (7.4 %) | 41.01 | 19.8 % | 0.26 |
Q2 2015 | 137.36 | 12.9 % | 63.56 | 18.4 % | 36.89 | 3.6 % | 0.23 |
Q3 2015 | 136.80 | 25.7 % | 57.97 | 29.6 % | 27.69 | 8.9 % | 0.17 |
Q4 2015 | 157.70 | 21.8 % | 68.06 | 21.6 % | 35.75 | 6.0 % | 0.22 |
2015 | 561.33 | 16.5 % | 240.24 | 14.9 % | 141.33 | 9.6 % | 0.88 |
Q1 2016 | 144.16 | 11.3 % | 54.75 | 8.1 % | 21.14 | (48.5 %) | 0.13 |
Q2 2016 | 138.08 | 0.5 % | 57.56 | (9.5 %) | 20.63 | (44.1 %) | 0.13 |
Q3 2016 | 141.35 | 3.3 % | 56.48 | (2.6 %) | 20.73 | (25.1 %) | 0.13 |
Q4 2016 | 182.65 | 15.8 % | 73.35 | 7.8 % | 10.48 | (70.7 %) | 0.07 |
2016 | 606.24 | 8.0 % | 242.13 | 0.8 % | 72.96 | (48.4 %) | 0.46 |
Q1 2017 | 180.23 | 25.0 % | 62.02 | 13.3 % | 27.97 | 32.3 % | 0.17 |
Q2 2017 | 176.71 | 28.0 % | 58.16 | 1.0 % | 25.66 | 24.4 % | 0.16 |
Q3 2017 | 163.01 | 15.3 % | 53.91 | (4.5 %) | 23.59 | 13.8 % | 0.15 |
Q4 2017 | 188.69 | 3.3 % | 65.08 | (11.3 %) | 30.76 | 193.4 % | 0.19 |
2017 | 708.62 | 16.9 % | 239.16 | (1.2 %) | 107.97 | 48.0 % | 0.67 |
Q1 2018 | 200.67 | 11.3 % | 66.84 | 7.8 % | 30.88 | 10.4 % | 0.19 |
Q2 2018 | 214.49 | 21.4 % | 53.28 | (8.4 %) | 19.93 | (22.3 %) | 0.12 |
Q3 2018 | 250.40 | 53.6 % | 64.92 | 20.4 % | 21.31 | (9.7 %) | 0.13 |
Q4 2018 | 228.04 | 20.9 % | 65.32 | 0.4 % | 17.70 | (42.5 %) | 0.11 |
2018 | 893.60 | 26.1 % | 250.36 | 4.7 % | 89.81 | (16.8 %) | 0.56 |
Q1 2019 | 229.68 | 14.5 % | 65.60 | (1.9 %) | 24.17 | (21.7 %) | 0.15 |
Q2 2019 | 253.83 | 18.3 % | 71.08 | 33.4 % | 20.01 | 0.4 % | 0.13 |
Q3 2019 | 220.00 | (12.1 %) | 62.22 | (4.2 %) | 21.17 | (0.6 %) | 0.13 |
Q4 2019 | 270.55 | 18.6 % | 83.72 | 28.2 % | 27.65 | 56.2 % | 0.17 |
2019 | 974.06 | 9.0 % | 282.62 | 12.9 % | 93.00 | 3.5 % | 0.58 |
Q1 2020 | 206.69 | (10.0 %) | 66.48 | 1.3 % | 24.94 | 3.2 % | 0.16 |
Q2 2020 | 244.30 | (3.8 %) | 90.81 | 27.7 % | 39.10 | 95.4 % | 0.24 |
Q3 2020 | 207.85 | (5.5 %) | 77.59 | 24.7 % | 36.57 | 72.7 % | 0.23 |
Q4 2020 | 230.47 | (14.8 %) | 68.48 | (18.2 %) | 30.21 | 9.3 % | 0.19 |
2020 | 764.06 | (21.6 %) | 252.83 | (10.5 %) | 130.83 | 40.7 % | 0.82 |
Q1 2021 | 226.29 | 9.5 % | 87.41 | 31.5 % | 35.54 | 42.5 % | 0.22 |
Q2 2021 | 223.90 | (8.4 %) | 79.96 | (11.9 %) | 40.31 | 3.1 % | 0.25 |
Q3 2021 | 219.92 | 5.8 % | 88.16 | 13.6 % | 3.58 | (90.2 %) | 0.02 |
Q4 2021 | 281.78 | 22.3 % | 108.53 | 58.5 % | 10.67 | (64.7 %) | 0.07 |
2021 | 951.89 | 24.6 % | 364.05 | 44.0 % | 90.09 | (31.1 %) | 0.56 |
Q1 2022 | 250.89 | 10.9 % | 96.08 | 9.9 % | 61.96 | 74.4 % | 0.39 |
Q2 2022 | 281.94 | 25.9 % | 109.09 | 36.4 % | 65.10 | 61.5 % | 0.41 |
Q3 2022 | 246.92 | 12.3 % | 83.50 | (5.3 %) | 57.11 | 1494.9 % | 0.36 |
Q4 2022 | 342.64 | 21.6 % | 131.00 | 20.7 % | 73.17 | 586.0 % | 0.46 |
2022 | 1,122.40 | 17.9 % | 419.67 | 15.3 % | 257.34 | 185.6 % | 1.61 |
Q1 2023 | 298.60 | 19.0 % | 120.20 | 25.1 % | 81.42 | 31.4 % | 0.51 |
Q2 2023 | 276.66 | (1.9 %) | 92.08 | (15.6 %) | 81.85 | 25.7 % | 0.51 |
Q3 2023 | 297.83 | 20.6 % | 112.87 | 35.2 % | 74.87 | 31.1 % | 0.47 |
Q4 2023 | 303.68 | (11.4 %) | 106.45 | (18.7 %) | 65.19 | (10.9 %) | 0.41 |
2023 | 1,176.76 | 4.8 % | 433.14 | 3.2 % | 303.33 | 17.9 % | 1.90 |
Q1 2024 | 277.04 | (7.2 %) | 91.06 | (24.2 %) | 64.04 | (21.3 %) | 0.40 |
Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
---|---|---|---|---|---|---|---|
2014 | 481.96 | 11.0 % | 209.11 | 12.9 % | 128.95 | 15.6 % | 0.81 |
2015 | 561.33 | 16.5 % | 240.24 | 14.9 % | 141.33 | 9.6 % | 0.88 |
2016 | 606.24 | 8.0 % | 242.13 | 0.8 % | 72.96 | (48.4 %) | 0.46 |
2017 | 708.62 | 16.9 % | 239.16 | (1.2 %) | 107.97 | 48.0 % | 0.67 |
2018 | 893.60 | 26.1 % | 250.36 | 4.7 % | 89.81 | (16.8 %) | 0.56 |
2019 | 974.06 | 9.0 % | 282.62 | 12.9 % | 93.00 | 3.5 % | 0.58 |
2020 | 764.06 | (21.6 %) | 252.83 | (10.5 %) | 130.83 | 40.7 % | 0.82 |
2021 | 951.89 | 24.6 % | 364.05 | 44.0 % | 90.09 | (31.1 %) | 0.56 |
2022 | 1,122.40 | 17.9 % | 419.67 | 15.3 % | 257.34 | 185.6 % | 1.61 |
2023 | 1,176.76 | 4.8 % | 433.14 | 3.2 % | 303.33 | 17.9 % | 1.90 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2015 | 41.90 % | 29.13 % | 25.73 % |
Q2 2015 | 42.55 % | 28.68 % | 25.19 % |
Q3 2015 | 42.80 % | 29.71 % | 24.29 % |
Q4 2015 | 42.80 % | 31.06 % | 23.43 % |
2015 | 42.80 % | 31.06 % | 23.43 % |
Q1 2016 | 42.42 % | 30.79 % | 21.09 % |
Q2 2016 | 41.32 % | 30.64 % | 18.24 % |
Q3 2016 | 40.74 % | 29.96 % | 16.90 % |
Q4 2016 | 39.94 % | 25.11 % | 12.04 % |
2016 | 39.94 % | 25.10 % | 12.03 % |
Q1 2017 | 38.83 % | 24.74 % | 12.43 % |
Q2 2017 | 36.71 % | 24.09 % | 12.46 % |
Q3 2017 | 35.22 % | 23.41 % | 12.48 % |
Q4 2017 | 33.75 % | 25.39 % | 15.24 % |
2017 | 33.75 % | 25.39 % | 15.24 % |
Q1 2018 | 33.46 % | 26.03 % | 15.21 % |
Q2 2018 | 31.18 % | 25.45 % | 13.71 % |
Q3 2018 | 29.28 % | 24.60 % | 12.04 % |
Q4 2018 | 28.02 % | 24.14 % | 10.05 % |
2018 | 28.02 % | 24.14 % | 10.05 % |
Q1 2019 | 27.00 % | 22.96 % | 9.01 % |
Q2 2019 | 27.75 % | 22.56 % | 8.65 % |
Q3 2019 | 28.36 % | 23.59 % | 8.92 % |
Q4 2019 | 29.01 % | 23.82 % | 9.55 % |
2019 | 29.01 % | 23.82 % | 9.55 % |
Q1 2020 | 29.81 % | 25.12 % | 9.86 % |
Q2 2020 | 32.21 % | 27.70 % | 12.52 % |
Q3 2020 | 34.28 % | 29.29 % | 14.34 % |
Q4 2020 | 34.11 % | 28.49 % | 15.27 % |
2020 | 33.09 % | 27.20 % | 17.78 % |
Q1 2021 | 35.68 % | 26.87 % | 16.11 % |
Q2 2021 | 35.28 % | 25.58 % | 16.05 % |
Q3 2021 | 35.98 % | 26.21 % | 16.52 % |
Q4 2021 | 38.24 % | 24.65 % | 14.60 % |
2021 | 38.24 % | 24.65 % | 14.60 % |
Q1 2022 | 38.17 % | 28.20 % | 16.94 % |
Q2 2022 | 38.84 % | 29.87 % | 18.38 % |
Q3 2022 | 37.42 % | 29.18 % | 19.27 % |
Q4 2022 | 37.39 % | 32.36 % | 22.93 % |
2022 | 37.39 % | 32.36 % | 22.93 % |
Q1 2023 | 37.93 % | 32.83 % | 23.66 % |
Q2 2023 | 36.64 % | 34.47 % | 25.20 % |
Q3 2023 | 37.52 % | 35.21 % | 25.61 % |
Q4 2023 | 36.68 % | 35.12 % | 25.23 % |
2023 | 36.81 % | 35.12 % | 25.23 % |
Q1 2024 | 34.84 % | 34.23 % | 24.19 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2014 | 43.39 % | 30.07 % | 26.75 % |
2015 | 42.80 % | 31.06 % | 23.43 % |
2016 | 39.94 % | 25.10 % | 12.03 % |
2017 | 33.75 % | 25.39 % | 15.24 % |
2018 | 28.02 % | 24.14 % | 10.05 % |
2019 | 29.01 % | 23.82 % | 9.55 % |
2020 | 33.09 % | 27.20 % | 17.78 % |
2021 | 38.24 % | 24.65 % | 14.60 % |
2022 | 37.39 % | 32.36 % | 22.93 % |
2023 | 36.81 % | 35.12 % | 25.23 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2015 | 39.11 % | 28.49 % | 24.10 % |
Q2 2015 | 46.28 % | 30.21 % | 26.86 % |
Q3 2015 | 42.37 % | 30.62 % | 20.24 % |
Q4 2015 | 43.16 % | 34.31 % | 22.67 % |
Q1 2016 | 37.98 % | 27.65 % | 14.66 % |
Q2 2016 | 41.68 % | 29.60 % | 14.94 % |
Q3 2016 | 39.95 % | 27.83 % | 14.67 % |
Q4 2016 | 40.16 % | 17.59 % | 5.74 % |
Q1 2017 | 34.41 % | 25.82 % | 15.52 % |
Q2 2017 | 32.91 % | 26.06 % | 14.52 % |
Q3 2017 | 33.07 % | 24.41 % | 14.47 % |
Q4 2017 | 34.49 % | 25.21 % | 16.30 % |
Q1 2018 | 33.31 % | 28.10 % | 15.39 % |
Q2 2018 | 24.84 % | 23.98 % | 9.29 % |
Q3 2018 | 25.93 % | 21.86 % | 8.51 % |
Q4 2018 | 28.65 % | 23.30 % | 7.76 % |
Q1 2019 | 28.56 % | 22.87 % | 10.52 % |
Q2 2019 | 28.00 % | 22.30 % | 7.88 % |
Q3 2019 | 28.28 % | 26.14 % | 9.62 % |
Q4 2019 | 30.94 % | 24.16 % | 10.22 % |
Q1 2020 | 32.17 % | 28.77 % | 12.07 % |
Q2 2020 | 37.17 % | 32.12 % | 18.05 % |
Q3 2020 | 37.33 % | 33.16 % | 17.59 % |
Q4 2020 | 29.72 % | 20.18 % | 13.11 % |
Q1 2021 | 38.63 % | 22.24 % | 15.70 % |
Q2 2021 | 35.71 % | 27.50 % | 18.00 % |
Q3 2021 | 40.09 % | 35.31 % | 19.45 % |
Q4 2021 | 38.51 % | 16.01 % | 7.22 % |
Q1 2022 | 38.29 % | 36.27 % | 24.70 % |
Q2 2022 | 38.69 % | 33.79 % | 23.09 % |
Q3 2022 | 33.82 % | 31.75 % | 23.13 % |
Q4 2022 | 38.23 % | 28.77 % | 21.35 % |
Q1 2023 | 40.25 % | 37.48 % | 27.27 % |
Q2 2023 | 33.28 % | 40.70 % | 29.58 % |
Q3 2023 | 37.90 % | 35.24 % | 25.14 % |
Q4 2023 | 35.05 % | 27.59 % | 19.34 % |
Q1 2024 | 32.87 % | 33.96 % | 23.12 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2015 | 160.00 | 0.85 | 0.79 | 8.51 |
Q2 2015 | 160.00 | 0.86 | 0.80 | 8.27 |
Q3 2015 | 160.00 | 0.87 | 0.81 | 8.44 |
Q4 2015 | 160.00 | 0.88 | 0.82 | 8.66 |
Q1 2016 | 160.00 | 0.76 | 0.76 | 8.80 |
Q2 2016 | 160.00 | 0.66 | 0.66 | 8.37 |
Q3 2016 | 160.00 | 0.61 | 0.61 | 8.50 |
Q4 2016 | 160.00 | 0.46 | 0.46 | 8.56 |
Q1 2017 | 160.00 | 0.50 | 0.50 | 8.75 |
Q2 2017 | 160.00 | 0.53 | 0.53 | 8.89 |
Q3 2017 | 160.00 | 0.55 | 0.55 | 9.04 |
Q4 2017 | 160.00 | 0.67 | 0.67 | 8.67 |
Q1 2018 | 160.00 | 0.69 | 0.69 | 8.85 |
Q2 2018 | 160.00 | 0.66 | 0.66 | 8.98 |
Q3 2018 | 160.00 | 0.64 | 0.64 | 9.11 |
Q4 2018 | 160.00 | 0.56 | 0.56 | 9.24 |
Q1 2019 | 160.00 | 0.52 | 0.52 | 9.40 |
Q2 2019 | 160.00 | 0.52 | 0.52 | 9.51 |
Q3 2019 | 160.00 | 0.52 | 0.52 | 9.63 |
Q4 2019 | 160.00 | 0.58 | 0.58 | 9.79 |
Q1 2020 | 160.00 | 0.59 | 0.59 | 9.95 |
Q2 2020 | 160.00 | 0.71 | 0.74 | 10.21 |
Q3 2020 | 160.00 | 0.80 | 0.83 | 10.42 |
Q4 2020 | 160.00 | 0.82 | 0.85 | 10.62 |
Q1 2021 | 160.00 | 0.88 | 0.92 | 10.47 |
Q2 2021 | 160.00 | 0.89 | 0.89 | 10.73 |
Q3 2021 | 160.00 | 0.69 | 0.93 | 10.75 |
Q4 2021 | 160.00 | 0.56 | 0.87 | 10.37 |
Q1 2022 | 160.00 | 0.73 | 1.03 | 10.47 |
Q2 2022 | 160.00 | 0.88 | 1.19 | 10.56 |
Q3 2022 | 160.00 | 1.22 | 1.28 | 10.61 |
Q4 2022 | 160.00 | 1.61 | 1.61 | 10.69 |
Q1 2023 | 160.00 | 1.73 | 1.73 | 10.85 |
Q2 2023 | 160.00 | 1.83 | 1.83 | 11.01 |
Q3 2023 | 160.00 | 1.95 | 1.95 | 11.49 |
Q4 2023 | 160.00 | 1.90 | 1.86 | 11.53 |
Q1 2024 | 160.00 | 1.79 | 1.75 | 11.58 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2014 | 160.00 | 0.81 | 0.81 | 8.25 |
2015 | 160.00 | 0.88 | 0.82 | 8.66 |
2016 | 160.00 | 0.46 | 0.46 | 8.56 |
2017 | 160.00 | 0.67 | 0.67 | 8.67 |
2018 | 160.00 | 0.56 | 0.56 | 9.24 |
2019 | 160.00 | 0.58 | 0.58 | 9.79 |
2020 | 160.00 | 0.82 | 0.85 | 10.62 |
2021 | 160.00 | 0.56 | 0.87 | 10.37 |
2022 | 160.00 | 1.61 | 1.61 | 10.69 |
2023 | 160.00 | 1.90 | 1.86 | 11.53 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2015 | 51.53 | 55.54 | 5.14 |
Q2 2015 | 54.13 | 58.30 | 5.61 |
Q3 2015 | 44.33 | 47.69 | 4.57 |
Q4 2015 | 41.63 | 44.73 | 4.24 |
Q1 2016 | 36.41 | 36.41 | 3.14 |
Q2 2016 | 45.86 | 45.86 | 3.60 |
Q3 2016 | 36.32 | 36.32 | 2.62 |
Q4 2016 | 68.31 | 68.31 | 3.64 |
Q1 2017 | 61.37 | 61.37 | 3.50 |
Q2 2017 | 58.51 | 58.51 | 3.49 |
Q3 2017 | 47.94 | 47.94 | 2.91 |
Q4 2017 | 41.25 | 41.25 | 3.21 |
Q1 2018 | 39.28 | 39.28 | 3.07 |
Q2 2018 | 37.68 | 37.68 | 2.76 |
Q3 2018 | 32.21 | 32.21 | 2.27 |
Q4 2018 | 33.55 | 33.55 | 2.04 |
Q1 2019 | 35.91 | 35.91 | 1.98 |
Q2 2019 | 30.97 | 30.97 | 1.69 |
Q3 2019 | 32.09 | 32.09 | 1.73 |
Q4 2019 | 27.16 | 27.16 | 1.61 |
Q1 2020 | 24.17 | 24.17 | 1.42 |
Q2 2020 | 23.40 | 22.41 | 1.62 |
Q3 2020 | 27.10 | 26.08 | 2.08 |
Q4 2020 | 26.52 | 25.54 | 2.04 |
Q1 2021 | 24.66 | 23.82 | 2.08 |
Q2 2021 | 33.33 | 33.33 | 2.77 |
Q3 2021 | 42.10 | 31.02 | 2.68 |
Q4 2021 | 53.70 | 34.82 | 2.92 |
Q1 2022 | 46.73 | 32.92 | 3.25 |
Q2 2022 | 41.33 | 30.71 | 3.46 |
Q3 2022 | 36.83 | 35.09 | 4.23 |
Q4 2022 | 24.93 | 24.93 | 3.75 |
Q1 2023 | 28.18 | 28.18 | 4.49 |
Q2 2023 | 33.19 | 33.19 | 5.53 |
Q3 2023 | 26.78 | 26.78 | 4.53 |
Q4 2023 | 31.33 | 32.01 | 5.15 |
Q1 2024 | 32.45 | 33.20 | 5.01 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2014 | 48.92 | 48.92 | 4.78 |
2015 | 41.63 | 44.73 | 4.24 |
2016 | 68.34 | 68.34 | 3.64 |
2017 | 41.25 | 41.25 | 3.21 |
2018 | 33.55 | 33.55 | 2.04 |
2019 | 27.16 | 27.16 | 1.61 |
2020 | 26.52 | 25.54 | 2.04 |
2021 | 53.70 | 34.82 | 2.92 |
2022 | 24.93 | 24.93 | 3.75 |
2023 | 31.33 | 32.01 | 5.15 |
Q1 2024
2024
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
Q1 2017 | 150.74 | 29.49 |
Q2 2017 | 147.45 | 29.26 |
Q3 2017 | 136.70 | 26.31 |
Q4 2017 | 155.95 | 32.73 |
Q1 2018 | 140.85 | 59.82 |
Q2 2018 | 143.64 | 71.39 |
Q3 2018 | 140.83 | 109.03 |
Q4 2018 | 154.81 | 73.23 |
Q1 2019 | 146.91 | 82.77 |
Q2 2019 | 151.05 | 102.78 |
Q3 2019 | 149.00 | 71.00 |
Q4 2019 | 177.92 | 92.62 |
Q1 2020 | 152.48 | 54.21 |
Q2 2020 | 192.83 | 51.46 |
Q3 2020 | 47.34 | 35.26 |
Q4 2020 | 185.43 | 45.04 |
Q1 2021 | 168.82 | 57.47 |
Q2 2021 | 163.87 | 60.02 |
Q3 2021 | 180.27 | 39.64 |
Q4 2021 | 224.93 | 56.85 |
Q1 2022 | 195.39 | 55.50 |
Q2 2022 | 232.25 | 49.69 |
Q3 2022 | 201.88 | 45.04 |
Q4 2022 | 241.22 | 101.43 |
Q1 2023 | 238.75 | 59.85 |
Q2 2023 | 217.85 | 58.80 |
Q3 2023 | 242.76 | 55.06 |
Q4 2023 | 251.51 | 52.17 |
Q1 2024 | 227.43 | 49.61 |
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
2014 | 360.30 | 121.61 |
2015 | 451.60 | 109.71 |
2016 | 552.40 | 89.11 |
2017 | 590.84 | 117.78 |
2018 | 580.13 | 313.47 |
2019 | 624.88 | 349.18 |
2020 | 578.09 | 185.97 |
2021 | 737.90 | 213.99 |
2022 | 870.74 | 251.65 |
2023 | 950.87 | 225.89 |
Item | Q1 2024 (e) | Q1 2024 (a) | Change |
---|---|---|---|
Average | 81.97 | 64.04 | (21.9 %) |
Item | Q1 2024 (e) | Q1 2024 (a) | Change |
---|---|---|---|
AlJazira Capital | 75.50 | 64.04 | (15.2) % |
Al Rajhi Capital | 78.00 | 64.04 | (17.9) % |
SNB Capital | 80.00 | 64.04 | (19.9) % |
OSOOL AND BAKHEET | 84.29 | 64.04 | (24.0) % |
U-Capital | 86.00 | 64.04 | (25.5) % |
Hermes | 88.00 | 64.04 | (27.2) % |
Current | |
Market Cap (M Riyal) | 7,480.00 |
Enterprise Value (EV) (M) | 7,478.11 |
Shares Outstanding ((M)) | 160.00 |
EPS ( Riyal) (TTM) | 1.79 |
Book Value (BV) ( Riyal) | 11.58 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 26.76 |
P/E (TTM) | 26.16 |
Price/book | 4.04 |
Return on Average Assets (%) (TTM) | 11.1 |
Return on Average Equity (%) (TTM) | 15.9 |
Company | Estimated | Actual | Change |
---|---|---|---|
MIS | 42.00 | 73.09 | 74.0 % |
SACO | (9.40) | (4.55) | 51.6 % |
RIYADH CEMENT | 58.00 | 70.10 | 20.9 % |
ALARABIA | 89.43 | 100.82 | 12.7 % |
CHEMANOL | (18.00) | (24.48) | (36.0 %) |
CENOMI RETAIL | (76.19) | (151.82) | (99.3 %) |
Company | Estimated | Actual | Change |
---|---|---|---|
AVALON PHARMA | 1.97 | 9.37 | 375.6 % |
MIS | 42.00 | 73.09 | 74.0 % |
SACO | (9.40) | (4.55) | 51.6 % |
RIYADH CEMENT | 58.00 | 70.10 | 20.9 % |
TCC | 13.60 | 16.11 | 18.5 % |
DAR ALARKAN | 131.20 | 153.59 | 17.1 % |
ALARABIA | 89.43 | 100.82 | 12.7 % |
Company | Estimated | Actual | Change |
---|---|---|---|
ALAMAR | 9.00 | (16.62) | (284.7 %) |
CENOMI RETAIL | (76.19) | (151.82) | (99.3 %) |
CHEMANOL | (18.00) | (24.48) | (36.0 %) |
ALHAMMADI | 81.97 | 64.04 | (21.9 %) |
NAJRAN CEMENT | 27.55 | 21.55 | (21.8 %) |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}